Interventions for valvular disease and heart failure
RenalGuard System for the prevention of acute kidney injury in patients undergoing transcatheter aortic valve implantation
EuroIntervention 2016;11:e1658-e1661 published online e-edition April 2016. DOI: 10.4244/EIJV11I14A317
Gabriella Visconti1, MD; Amelia Focaccio1, MD; Michael Donahue1, MD; Bruno Golia1, MD; Antonio Marzano1, MD; Elvira Donnarumma2, PhD; Bruno Ricciardelli1, MD; Lucio Selvetella3, MD; Luigi Marino4, MD; Carlo Briguori1*, MD, PhD
1. Laboratory of Interventional Cardiology and Department of Cardiology, Clinica Mediterranea, Naples, Italy; 2. IRCCS SDN, Naples, Italy; 3. Department of Vascular Surgery, Clinica Mediterranea, Naples, Italy; 4. Department of Cardiac Surgery, Clinica Me
Aims: We aimed to assess whether the RenalGuard™ System is effective in preventing acute kidney injury (AKI) following transcatheter aortic valve implantation (TAVI).